President Donald Trump signed an executive memorandum on Tuesday ordering his administration to address misleading direct-to-consumer (DTC) drug advertising and to ensure “transparency and accuracy.”
In the memo, Trump instructed the Department of Health and Human Services (HHS) to take “appropriate action” on regulation surrounding drug advertising, including more disclosures about side effects.
“The FDA [Food and Drug Administration] has historically stipulated that a manufacturer, packer, or distributor must provide the public with materially complete information that fairly balances both the benefits and the risks of the drug,” the memo stated.
Read more at Newsmax© 2025 Newsmax. All rights reserved.
